Evidence map›Paper›PMID 19735695›Full record

ArticleNeuroscience letters2009

Neuroprotective effects of testosterone on dendritic morphology following partial motoneuron depletion: efficacy in female rats.

Randall E Wilson, Kellie D Coons, Dale R Sengelaub

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Inhibition of Cytosolic Phospholipase AJournal of neurotrauma · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Randall E WilsonProgram in Neuroscience and Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN 47405, United States.
Kellie D Coons
Dale R Sengelaub
Indiana University Bloomington · US

Funding

PREVENTION OF DENDRITIC ATROPHY AFTER MOTONEURON INJURYR01NS047264 · NINDS · TRUSTEES OF INDIANA UNIVERSITY · PI SENGELAUB, DALE R · 2005 to 2009
$979k
NINDS NIH HHS NS047264NINDS NIH HHS R01 NS047264
6 · The paper itself

Abstract

Motoneuron loss is a significant medical problem, capable of causing severe movement disorders and even death. We have previously demonstrated that partial depletion of motoneurons induces dendritic atrophy in remaining motoneurons, with a concomitant reduction in motor activation. Treatment of male rats with testosterone attenuates the regressive changes following partial motoneuron depletion. To test whether testosterone has similar effects in females, we examined potential neuroprotective effects in motoneurons innervating muscles of the quadriceps of female rats. Motoneurons were selectively killed by intramuscular injection of cholera toxin-conjugated saporin. Simultaneously, some saporin-injected rats were given implants containing testosterone or left untreated. Four weeks later, surviving motoneurons were labeled with cholera toxin-conjugated HRP, and dendritic arbors were reconstructed in three dimensions. Compared to normal females, partial motoneuron depletion resulted in decreased dendritic length in remaining quadriceps motoneurons, and this atrophy was greatly attenuated by testosterone treatment. These findings suggest that testosterone has neuroprotective effects on morphology in both males and females, further supporting a role for testosterone as a neurotherapeutic agent in the injured nervous system.

Indexed as

AnimalsCell SurvivalDelayed-Action PreparationsDendritesFemaleMotor Neuron DiseaseMotor NeuronsMuscle, SkeletalNeuroprotective AgentsOrgan SizeRatsRats, Sprague-DawleyRibosome Inactivating Proteins, Type 1SaporinsSpinal CordTestosteroneDelayed-Action PreparationsNeuroprotective AgentsRibosome Inactivating Proteins, Type 1SaporinsTestosterone

Identifiers

PMID19735695
PMCPMC2755210
OpenAlexW1976173583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.